Literature DB >> 17446429

Predictive variables for mortality after acute ischemic stroke.

Angela M Carter1, Andrew J Catto, Michael W Mansfield, John M Bamford, Peter J Grant.   

Abstract

BACKGROUND AND
PURPOSE: Stroke is a major healthcare issue worldwide with an incidence comparable to coronary events, highlighting the importance of understanding risk factors for stroke and subsequent mortality.
METHODS: In the present study, we determined long-term (all-cause) mortality in 545 patients with ischemic stroke compared with a cohort of 330 age-matched healthy control subjects followed up for a median of 7.4 years. We assessed the effect of selected demographic, clinical, biochemical, hematologic, and hemostatic factors on mortality in patients with ischemic stroke. Stroke subtype was classified according to the Oxfordshire Community Stroke Project criteria. Patients who died 30 days or less after the acute event (n=32) were excluded from analyses because this outcome is considered to be directly attributable to the acute event.
RESULTS: Patients with ischemic stroke were at more than 3-fold increased risk of death compared with the age-matched control cohort. In multivariate analyses, age, stroke subtype, atrial fibrillation, and previous stroke/transient ischemic attack were predictive of mortality in patients with ischemic stroke. Albumin and creatinine and the hemostatic factors von Willebrand factor and beta-thromboglobulin were also predictive of mortality in patients with ischemic stroke after accounting for demographic and clinical variables.
CONCLUSIONS: The results indicate that subjects with acute ischemic stroke are at increased risk of all-cause mortality. Advancing age, large-vessel stroke, atrial fibrillation, and previous stroke/transient ischemic attack predict mortality; and analysis of albumin, creatinine, von Willebrand factor, and beta-thromboglobulin will aid in the identification of patients at increased risk of death after stroke.

Entities:  

Mesh:

Year:  2007        PMID: 17446429     DOI: 10.1161/STROKEAHA.106.474569

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  Clinical role of von Willebrand factor in acute ischemic stroke.

Authors:  Marija Menih; Miljenko Križmarić; Tanja Hojs Fabjan
Journal:  Wien Klin Wochenschr       Date:  2017-04-13       Impact factor: 1.704

2.  Renal function predicts survival in patients with acute ischemic stroke.

Authors:  Elizabeth Mostofsky; Gregory A Wellenius; Amit Noheria; Emily B Levitan; Mary R Burger; Gottfried Schlaug; Murray A Mittleman
Journal:  Cerebrovasc Dis       Date:  2009-05-20       Impact factor: 2.762

Review 3.  Ischemic stroke in the elderly: an overview of evidence.

Authors:  Ruo-Li Chen; Joyce S Balami; Margaret M Esiri; Liang-Kung Chen; Alastair M Buchan
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

Review 4.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

Review 5.  Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.

Authors:  Hakan Sarikaya
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

6.  [Indication for emergent revascularisation of acute carotid occlusion].

Authors:  B T Weis-Müller; R Huber; A Spivak-Dats; B Turowski; R Seitz; M Siebler; W Sandmann
Journal:  Chirurg       Date:  2007-11       Impact factor: 0.955

7.  Prestroke factors associated with poststroke mortality and recovery in older women in the Women's Health Initiative.

Authors:  Christina L Bell; Andrea LaCroix; Kamal Masaki; Erinn M Hade; Todd Manini; W Jerry Mysiw; Jess David Curb; Sylvia Wassertheil-Smoller
Journal:  J Am Geriatr Soc       Date:  2013-07-19       Impact factor: 5.562

8.  Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study.

Authors:  R F Gottesman; C Cummiskey; L Chambless; K K Wu; N Aleksic; A R Folsom; A R Sharrett
Journal:  Cerebrovasc Dis       Date:  2009-10-16       Impact factor: 2.762

9.  Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.

Authors:  Nicole Lüneburg; Wolfgang Lieb; Tanja Zeller; Ming-Huei Chen; Renke Maas; Angela M Carter; Vanessa Xanthakis; Nicole L Glazer; Edzard Schwedhelm; Sudha Seshadri; Mohammad Arfan Ikram; William T Longstreth; Myriam Fornage; Inke R König; Christina Loley; Francisco M Ojeda; Arne Schillert; Thomas J Wang; Heinrich Sticht; Anja Kittel; Jörg König; Emelia J Benjamin; Lisa M Sullivan; Isabel Bernges; Maike Anderssohn; Andreas Ziegler; Christian Gieger; Thomas Illig; Christa Meisinger; H-Erich Wichmann; Philipp S Wild; Heribert Schunkert; Bruce M Psaty; Kerri L Wiggins; Susan R Heckbert; Nicholas Smith; Karl Lackner; Kathryn L Lunetta; Stefan Blankenberg; Jeanette Erdmann; Thomas Munzel; Peter J Grant; Ramachandran S Vasan; Rainer H Böger
Journal:  Circ Cardiovasc Genet       Date:  2014-09-21

10.  Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram.

Authors:  Gretchen N Neigh; Christina L Nemeth; Sean D Kelly; Emily E Hardy; Chase Bourke; Zachary N Stowe; Michael J Owens
Journal:  Physiol Behav       Date:  2016-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.